{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:05:30Z","timestamp":1777363530420,"version":"3.51.4"},"reference-count":101,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2019.01558","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T05:23:01Z","timestamp":1579670581000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["An Update on Molecular Biology of Cutaneous T Cell Lymphoma"],"prefix":"10.3389","volume":"9","author":[{"given":"Ritika","family":"Walia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia C. S.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,1,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/ng.3442","article-title":"The mutational landscape of cutaneous T cell lymphoma and S\u00e9zary syndrome","volume":"47","author":"da Silva Almeida","year":"2015","journal-title":"Nat Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1182\/blood-2014-11-611194","article-title":"Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides","volume":"126","author":"McGirt","year":"2015","journal-title":"Blood."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/ng.3356","article-title":"Genomic landscape of cutaneous T cell lymphoma","volume":"47","author":"Choi","year":"2015","journal-title":"Nat Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/ng.3370","article-title":"Genomic analysis of mycosis fungoides and S\u00e9zary syndrome identifies recurrent alterations in TNFR2","volume":"47","author":"Ungewickell","year":"2015","journal-title":"Nat Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11864-016-0410-8","article-title":"Genetics of cutaneous T cell lymphoma: from bench to bedside","volume":"17","author":"Damsky","year":"2016","journal-title":"Curr Treat Options Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/ng.3444","article-title":"Genomic profiling of S\u00e9zary syndrome identifies alterations of key T cell signaling and differentiation genes","volume":"47","author":"Wang","year":"2015","journal-title":"Nat Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/mgg3.121","article-title":"Personalized treatment of S\u00e9zary syndrome by targeting a novel CTLA4:CD28 fusion","volume":"3","author":"Sekulic","year":"2015","journal-title":"Mol Genet Genomic Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1053\/hupa.2000.20370","article-title":"Constitutive expression of NF-kappa B is a characteristic feature of mycosis fungoides: implications for apoptosis resistance and pathogenesis","volume":"31","author":"Izban","year":"2000","journal-title":"Hum Pathol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.4049\/jimmunol.1402610","article-title":"Bortezomib inhibits expression of TGF-\u03b21, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells","volume":"194","author":"Chang","year":"2015","journal-title":"J Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.3324\/haematol.2015.132837","article-title":"Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma","volume":"100","author":"P\u00e9rez","year":"2015","journal-title":"Haematologica."},{"key":"B13","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/gcc.22679","article-title":"Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides","volume":"57","author":"Bastidas Torres","year":"2018","journal-title":"Genes Chromosomes Cancer."},{"key":"B14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1749-6632.2001.tb03707.x","article-title":"Analysis of clonality in cutaneous T cell lymphoma and associated diseases","volume":"941","author":"Wood","year":"2001","journal-title":"Ann N Y Acad Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1046\/j.1523-1747.2000.00040.x","article-title":"Detection of expanded T cell clones in skin biopsy samples of patients with lichen sclerosus et atrophicus by T cell receptor-gamma polymerase chain reaction assays","volume":"115","author":"Lukowsky","year":"2000","journal-title":"J Invest Dermatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1365-2133.2005.06649.x","article-title":"T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction\/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides\/S\u00e9zary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings","volume":"153","author":"Ponti","year":"2005","journal-title":"Br J Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/cup.13072","article-title":"Views of dermatopathologists about clonality assays in the diagnosis of cutaneous T-cell and B-cell lymphoproliferative disorders","volume":"45","author":"Comfere","year":"2018","journal-title":"J Cutan Pathol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"205.e201","DOI":"10.1016\/j.jaad.2013.07.049","article-title":"Primary cutaneous T-cell lymphoma (mycosis fungoides and S\u00e9zary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers","volume":"70","author":"Jawed","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.5732\/cjc.010.10344","article-title":"Diagnostic significance of TCR gene clonal rearrangement analysis in early mycosis fungoides","volume":"30","author":"Xu","year":"2011","journal-title":"Chin J Cancer."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jcp.56.1.1","article-title":"Diagnostic role of tests for T cell receptor (TCR) genes","volume":"56","author":"Hodges","year":"2003","journal-title":"J Clin Pathol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0929-6646(09)60251-5","article-title":"Histopathologic-molecular correlation in early mycosis fungoides using T-cell receptor gamma gene rearrangement by polymerase chain reaction with laser capture microdissection","volume":"106","author":"Hsiao","year":"2007","journal-title":"J Formos Med Assoc."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/sj.jid.5701109","article-title":"TCRgamma-chain gene rearrangement by PCR-based GeneScan: diagnostic accuracy improvement and clonal heterogeneity analysis in multiple cutaneous T-cell lymphoma samples","volume":"128","author":"Ponti","year":"2008","journal-title":"J Invest Dermatol."},{"key":"B23","unstructured":"Molecular immunoglobulin\/T- cell receptor clonality analysis in cutaneous lymphoproliferations. Experience with the BIOMED-2 standardized polymerase chain reaction protocol65970\n            SandbergY\n            HeuleF\n            LamK\n            LugtenburgPJ\n            Wolvers-TetteroI\n            van DongenJJ\n          12801842Haematologica.882003"},{"key":"B24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/PDM.0b013e3181b2a1b7","article-title":"Evaluation of T-cell clonality in archival skin biopsy samples of cutaneous T-cell lymphomas using the biomed-2 PCR protocol","volume":"19","author":"Lukowsky","year":"2010","journal-title":"Diagn Mol Pathol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1525-1578(10)60630-7","article-title":"Pseudo-spikes are common in histologically benign lymphoid tissues","volume":"2","author":"Lee","year":"2000","journal-title":"J Mol Diagn."},{"key":"B26","unstructured":"A comparative study of polymerase chain reaction detection of clonal T-cell receptor gamma chain gene rearrangements using polyacrylamide gel electrophoresis versus fluorescence capillary electrophoresis2731\n            TangMB\n            ChongTK\n            TanES\n            SunY\n            TanSH\n          18265894Ann Acad Med Singapore.372008"},{"key":"B27","doi-asserted-by":"publisher","first-page":"308ra158","DOI":"10.1126\/scitranslmed.aaa9122","article-title":"TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL","volume":"7","author":"Kirsch","year":"2015","journal-title":"Sci Transl Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jaad.2015.04.030","article-title":"T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides","volume":"73","author":"Sufficool","year":"2015","journal-title":"J Am Acad Dermatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1136\/jclinpath-2018-205004","article-title":"Role of high-throughput sequencing in the diagnosis of cutaneous T-cell lymphoma","volume":"71","author":"Rea","year":"2018","journal-title":"J Clin Pathol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/(SICI)1096-9896(199906)188:2<146::AID-PATH334>3.0.CO;2-7","article-title":"Clonal T-cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in advanced cutaneous T-cell lymphoma: a critical evaluation","volume":"188","author":"Dippel","year":"1999","journal-title":"J Pathol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s004030000178","article-title":"Detection of clonal T cells in lichen planus","volume":"292","author":"Schiller","year":"2000","journal-title":"Arch Dermatol Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jaad.2007.06.004","article-title":"T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides","volume":"57","author":"Thurber","year":"2007","journal-title":"J Am Acad Dermatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jaad.2015.12.018","article-title":"Cutaneous T-cell lymphoma (CTCL): current practices in blood assessment and the utility of T-cell receptor (TCR)-V\u03b2 chain restriction","volume":"74","author":"Gibson","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/bjd.14017","article-title":"Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study Group","volume":"173","author":"Hurabielle","year":"2015","journal-title":"Br J Dermatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"214ra171","DOI":"10.1126\/scitranslmed.3007420","article-title":"Minimal residual disease monitoring with high-throughput sequencing of T cell receptors in cutaneous T cell lymphoma","volume":"5","author":"Weng","year":"2013","journal-title":"Sci Transl Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e86252","DOI":"10.1172\/jci.insight.86252","article-title":"Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide","volume":"1","author":"Kanakry","year":"2016","journal-title":"JCI Insight."},{"key":"B38","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jmoldx.2016.07.009","article-title":"Methodologic considerations in the application of next-generation sequencing of human TRB repertoires for clinical use","volume":"19","author":"Xu","year":"2017","journal-title":"J Mol Diagn."},{"key":"B39","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/j.1365-2133.2008.08761.x","article-title":"The prognosis of early mycosis fungoides is not influenced by phenotype and T-cell clonality","volume":"159","author":"Massone","year":"2008","journal-title":"Br J Dermatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"eaar5894","DOI":"10.1126\/scitranslmed.aar5894","article-title":"High-throughput sequencing of the T cell receptor \u03b2 gene identifies aggressive early-stage mycosis fungoides","volume":"10","author":"de Masson","year":"2018","journal-title":"Sci Transl Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"913523","DOI":"10.1155\/2012\/913523","article-title":"The role of molecular pathology in the diagnosis of cutaneous lymphomas","volume":"2012","author":"Raess","year":"2012","journal-title":"Patholog Res Int."},{"key":"B42","doi-asserted-by":"publisher","first-page":"320","DOI":"10.2353\/jmoldx.2010.090123","article-title":"Combined use of PCR-based TCRG and TCRB clonality tests on paraffin-embedded skin tissue in the differential diagnosis of mycosis fungoides and inflammatory dermatoses","volume":"12","author":"Zhang","year":"2010","journal-title":"J Mol Diagn."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1038\/leu.2012.246","article-title":"EuroClonality\/BIOMED-2 guidelines for interpretation and reporting of Ig\/TCR clonality testing in suspected lymphoproliferations","volume":"26","author":"Langerak","year":"2012","journal-title":"Leukemia."},{"key":"B44","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1309\/AJCP5TYGBVW4ZITR","article-title":"A comparison of deep sequencing of TCRG rearrangements vs traditional capillary electrophoresis for assessment of clonality in T-Cell lymphoproliferative disorders","volume":"141","author":"Schumacher","year":"2014","journal-title":"Am J Clin Pathol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1182\/bloodadvances.2018022608","article-title":"Single-cell heterogeneity in S\u00e9zary syndrome","volume":"2","author":"Buus","year":"2018","journal-title":"Blood Adv."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1158\/1078-0432.CCR-18-3309","article-title":"Single-cell profiling of cutaneous T-cell lymphoma reveals underlying heterogeneity associated with disease progression","volume":"25","author":"Borcherding","year":"2019","journal-title":"Clin Cancer Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"4443","DOI":"10.1158\/1078-0432.CCR-19-0148","article-title":"Single-cell lymphocyte heterogeneity in advanced Cutaneous T-Cell Lymphoma skin tumors","volume":"25","author":"Gaydosik","year":"2019","journal-title":"Clin Cancer Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nrc.2017.58","article-title":"Unravelling biology and shifting paradigms in cancer with single-cell sequencing","volume":"17","author":"Baslan","year":"2017","journal-title":"Nat Rev Cancer."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/s41556-018-0236-7","article-title":"Tumour heterogeneity and metastasis at single-cell resolution","volume":"20","author":"Lawson","year":"2018","journal-title":"Nat Cell Biol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-4939-3652-6_3","article-title":"Introduction to the gene expression analysis","volume":"1434","author":"Segundo-Val","year":"2016","journal-title":"Methods Mol Biol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/14737159.2017.1268533","article-title":"NanoString, a novel digital color-coded barcode technology: current and future applications in molecular diagnostics","volume":"17","author":"Tsang","year":"2017","journal-title":"Expert Rev Mol Diagn."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e1306618","DOI":"10.1080\/2162402X.2017.1306618","article-title":"Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators","volume":"6","author":"Litvinov","year":"2017","journal-title":"Oncoimmunology."},{"key":"B53","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood."},{"key":"B54","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood."},{"key":"B55","doi-asserted-by":"publisher","first-page":"269rv261","DOI":"10.1126\/scitranslmed.3010641","article-title":"Resident memory T cells in human health and disease","volume":"7","author":"Clark","year":"2015","journal-title":"Sci Transl Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1158\/1078-0432.CCR-14-3322","article-title":"The use of transcriptional profiling to improve personalized diagnosis and management of cutaneous T-cell lymphoma (CTCL)","volume":"21","author":"Litvinov","year":"2015","journal-title":"Clin Cancer Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1182\/blood-2005-07-2813","article-title":"Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy","volume":"107","author":"Nebozhyn","year":"2006","journal-title":"Blood."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1182\/blood-2012-10-460535","article-title":"Use of PLS3, Twist, CD158k\/KIR3DL2, and NKp46 gene expression combination for reliable S\u00e9zary syndrome diagnosis","volume":"121","author":"Michel","year":"2013","journal-title":"Blood."},{"key":"B59","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4103\/ijd.IJD_73_17","article-title":"New targeted treatments for cutaneous T-cell lymphomas","volume":"62","author":"Bagot","year":"2017","journal-title":"Indian J Dermatol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1080\/13543784.2018.1498081","article-title":"IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma","volume":"27","author":"Van Der Weyden","year":"2018","journal-title":"Expert Opin Investig Drugs."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/S1470-2045(18)30379-6","article-title":"Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial","volume":"19","author":"Kim","year":"2018","journal-title":"Lancet Oncol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1001\/jamadermatol.2019.0369","article-title":"Mogamulizumab-associated cutaneous granulomatous drug eruption mimicking mycosis fungoides but possibly indicating durable clinical response","volume":"155","author":"Chen","year":"2019","journal-title":"JAMA Dermatol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1038\/jid.2012.13","article-title":"Molecular markers of early-stage mycosis fungoides","volume":"132","author":"Zhang","year":"2012","journal-title":"J Invest Dermatol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.18632\/oncotarget.2031","article-title":"Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis","volume":"5","author":"Huang","year":"2014","journal-title":"Oncotarget."},{"key":"B65","unstructured":"TOX gene: a novel target for human cancer gene therapy351624\n            YuX\n            LiZ\n          26885442Am J Cancer Res.52015"},{"key":"B66","doi-asserted-by":"publisher","first-page":"5891","DOI":"10.1182\/blood-2011-06-358382","article-title":"Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)","volume":"118","author":"Ralfkiaer","year":"2011","journal-title":"Blood."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.3390\/ijms18102136","article-title":"Plasma miR-155, miR-203, and miR-205 are biomarkers for monitoring of primary cutaneous T-cell lymphomas","volume":"18","author":"Dus\u00edlkov\u00e1","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B68","unstructured":"MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma720717\n            RalfkiaerU\n            LindahlLM\n            LitmanT\n            GjerdrumL\n            AhlerCB\n            GniadeckiR\n          25503151Anticancer Res.342014"},{"key":"B69","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1182\/blood-2017-06-788950","article-title":"Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study","volume":"131","author":"Lindahl","year":"2018","journal-title":"Blood."},{"key":"B70","doi-asserted-by":"publisher","first-page":"39627","DOI":"10.18632\/oncotarget.17383","article-title":"Genetic rearrangements result in altered gene expression and novel fusion transcripts in S\u00e9zary syndrome","volume":"8","author":"Izykowska","year":"2017","journal-title":"Oncotarget."},{"key":"B71","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653.012k23_3653_3661","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1097\/PAS.0b013e3181e75356","article-title":"A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases","volume":"34","author":"Saggini","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1159\/000355479","article-title":"Primary cutaneous anaplastic large cell lymphoma with angioinvasive features and cytotoxic phenotype: a rare lymphoma variant within the spectrum of CD30+ lymphoproliferative disorders","volume":"227","author":"Kempf","year":"2013","journal-title":"Dermatology."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1097\/PAS.0b013e318282d01e","article-title":"Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis","volume":"37","author":"Karai","year":"2013","journal-title":"Am J Surg Pathol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/j.1600-0560.2006.00560.x","article-title":"Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30 lymphoproliferative disorders","volume":"33","author":"Greisser","year":"2006","journal-title":"J Cutan Pathol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.humpath.2014.12.008","article-title":"Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin","volume":"46","author":"de la Garza Bravo","year":"2015","journal-title":"Hum Pathol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.jid.2018.02.028","article-title":"SATB1 defines a subtype of cutaneous CD30","volume":"138","author":"Sun","year":"2018","journal-title":"J Invest Dermatol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/modpathol.2010.225","article-title":"Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies","volume":"24","author":"Wada","year":"2011","journal-title":"Mod Pathol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3324\/haematol.2018.197152","article-title":"CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies","volume":"104","author":"Prieto-Torres","year":"2019","journal-title":"Haematologica."},{"key":"B80","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/his.12529","article-title":"Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features","volume":"66","author":"Onaindia","year":"2015","journal-title":"Histopathology."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1111\/bjd.13690","article-title":"Assessment of diagnostic criteria between primary cutaneous anaplastic large-cell lymphoma and CD30-rich transformed mycosis fungoides; a study of 66 cases","volume":"172","author":"Fauconneau","year":"2015","journal-title":"Br J Dermatol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","article-title":"Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing","volume":"117","author":"Feldman","year":"2011","journal-title":"Blood."},{"key":"B83","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1182\/blood-2014-07-588434","article-title":"A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders","volume":"124","author":"Velusamy","year":"2014","journal-title":"Blood."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","article-title":"Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas","volume":"120","author":"Vasmatzis","year":"2012","journal-title":"Blood."},{"key":"B85","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3324\/haematol.2012.065664","article-title":"ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study","volume":"98","author":"Oschlies","year":"2013","journal-title":"Haematologica"},{"key":"B86","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/bjd.14626","article-title":"KIR3DL2 (CD158k) is a potential therapeutic target in primary cutaneous anaplastic large-cell lymphoma","volume":"175","author":"Battistella","year":"2016","journal-title":"Br J Dermatol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1600-0625.2012.01548.x","article-title":"Primary cutaneous anaplastic large cell lymphoma shows a distinct miRNA expression profile and reveals differences from tumor-stage mycosis fungoides","volume":"21","author":"Benner","year":"2012","journal-title":"Exp Dermatol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1046\/j.1365-2141.2003.04335.x","article-title":"Angioimmunoblastic T-cell lymphoma","volume":"121","author":"Dogan","year":"2003","journal-title":"Br J Haematol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/cup.13475","article-title":"Cutaneous lesions of angioimmunoblastic T-cell lymphoma: clinical, pathological, and immunophenotypic features","volume":"46","author":"Oishi","year":"2019","journal-title":"J Cutan Pathol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1097\/PAS.0000000000000956","article-title":"Expression of TFH markers and detection of RHOA p.G17V and IDH2 p.R172K\/S mutations in cutaneous localizations of angioimmunoblastic T-cell lymphomaS","volume":"41","author":"Leclaire Alirkilicarslan","year":"2017","journal-title":"Am J Surg Pathol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1097\/PAS.0000000000000651","article-title":"Clinicopathologic analysis of angioimmunoblastic T-cell lymphoma with or without RHOA G17V mutation using formalin-fixed paraffin-embedded sections","volume":"40","author":"Nagao","year":"2016","journal-title":"Am J Surg Pathol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/PAS.0000000000000555","article-title":"Angioimmunoblastic T-cell lymphomas with the RHOA p.Gly17Val mutation have classic clinical and pathologic features","volume":"40","author":"Ondrejka","year":"2016","journal-title":"Am J Surg Pathol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":"A targeted mutational landscape of angioimmunoblastic T-cell lymphoma","volume":"123","author":"Odejide","year":"2014","journal-title":"Blood."},{"key":"B95","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet."},{"key":"B96","doi-asserted-by":"publisher","first-page":"17763","DOI":"10.18632\/oncotarget.14846","article-title":"Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1182\/blood-2016-02-698977","article-title":"Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas","volume":"128","author":"Vallois","year":"2016","journal-title":"Blood."},{"key":"B98","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1365-2141.2009.08003.x","article-title":"Advances in the understanding and management of angioimmunoblastic T-cell lymphoma","volume":"148","author":"de Leval","year":"2010","journal-title":"Br J Haematol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"e516","DOI":"10.1038\/bcj.2016.122","article-title":"Identification of cell-type-specific mutations in nodal T-cell lymphomas","volume":"7","author":"Nguyen","year":"2017","journal-title":"Blood Cancer J."},{"key":"B100","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1200\/JCO.2014.60.3787","article-title":"Results of a phase II trial of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma and lymphomatoid papulosis","volume":"33","author":"Duvic","year":"2015","journal-title":"J Clin Oncol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1200\/JCO.2007.11.4207","article-title":"Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma","volume":"25","author":"Zinzani","year":"2007","journal-title":"J Clin Oncol."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.01558\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T05:23:06Z","timestamp":1579670586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.01558\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,22]]},"references-count":101,"alternative-id":["10.3389\/fonc.2019.01558"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2019.01558","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,22]]},"article-number":"1558"}}